These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 29786179)

  • 21. The uses and abuses of Vitamin D compounds in chronic kidney disease-mineral bone disease (CKD-MBD).
    Goldsmith DJ; Massy ZA; Brandenburg V
    Semin Nephrol; 2014 Nov; 34(6):660-8. PubMed ID: 25498384
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Is chronic kidney disease-mineral bone disorder (CKD-MBD) really a syndrome?
    Cozzolino M; Ureña-Torres P; Vervloet MG; Brandenburg V; Bover J; Goldsmith D; Larsson TE; Massy ZA; Mazzaferro S;
    Nephrol Dial Transplant; 2014 Oct; 29(10):1815-20. PubMed ID: 24516228
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Update on recent progress in vitamin D research. The role of vitamin D in management of CKD-MBD.].
    Hamano N; Fukagawa M
    Clin Calcium; 2017; 27(11):1609-1614. PubMed ID: 29074834
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chronic Kidney Disease-Mineral Bone Disorder in the Elderly Peritoneal Dialysis Patient.
    Heaf JG
    Perit Dial Int; 2015 Nov; 35(6):640-4. PubMed ID: 26702005
    [TBL] [Abstract][Full Text] [Related]  

  • 25. KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD).
    Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group
    Kidney Int Suppl; 2009 Aug; (113):S1-130. PubMed ID: 19644521
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hyperparathyroidism in chronic kidney disease patients: an update on current pharmacotherapy.
    Fukagawa M; Komaba H; Kakuta T
    Expert Opin Pharmacother; 2013 May; 14(7):863-71. PubMed ID: 23521343
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term management of CKD-mineral and bone disorder.
    Martin KJ; González EA
    Am J Kidney Dis; 2012 Aug; 60(2):308-15. PubMed ID: 22520454
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of secondary hyperparathyroidism in non-dialysis CKD: an appraisal 2022s.
    Ketteler M; Bover J; Mazzaferro S
    Nephrol Dial Transplant; 2023 May; 38(6):1397-1404. PubMed ID: 35977397
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of Pediatric Chronic Kidney Disease-Mineral and Bone Disorder.
    Hanudel MR; Salusky IB
    Curr Osteoporos Rep; 2017 Jun; 15(3):198-206. PubMed ID: 28455644
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [CKD-MBD (Chronic Kidney Disease-Mineral and Bone Disorder). Role of cinacalcet in the treatment of CKD-MBD].
    Koiwa F; Maruta Y
    Clin Calcium; 2010 Jul; 20(7):1089-95. PubMed ID: 20585188
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Calcimimetics, phosphate binders, vitamin D and its analogues for treating secondary hyperparathyroidism in chronic kidney disease: guideline from the Italian Society of Nephrology].
    Mazzaferro S; Cozzolino M; Marangella M; Strippoli GF; Messa P;
    G Ital Nefrol; 2007; 24 Suppl 37():S107-24. PubMed ID: 17347960
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
    Lorenzo Sellares V; Torregrosa V
    Nefrologia; 2008; 28 Suppl 3():67-78. PubMed ID: 19018742
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Kidney and bone update : the 5-year history and future of CKD-MBD. About the guideline of the Japanese Society for Dialysis Therapy].
    Yokoyama K
    Clin Calcium; 2012 Jul; 22(7):979-86. PubMed ID: 22750929
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Leveraging quantitative systems pharmacology and artificial intelligence to advance treatment of chronic kidney disease mineral bone disorder.
    Gaweda A; Brier M; Lederer E
    Am J Physiol Renal Physiol; 2024 Sep; 327(3):F351-F362. PubMed ID: 38961848
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Review article: Addressing risk factors in chronic kidney disease mineral and bone disorder: can we influence patient-level outcomes?
    O'Shea S; Johnson DW
    Nephrology (Carlton); 2009 Jun; 14(4):416-27. PubMed ID: 19563384
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Current concepts and management strategies in chronic kidney disease-mineral and bone disorder.
    Chauhan V; Kelepouris E; Chauhan N; Vaid M
    South Med J; 2012 Sep; 105(9):479-85. PubMed ID: 22948328
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bone disease in pediatric chronic kidney disease.
    Wesseling-Perry K
    Pediatr Nephrol; 2013 Apr; 28(4):569-76. PubMed ID: 23064662
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recommendations of the Spanish Society of Nephrology for the management of mineral and bone metabolism disorders in patients with chronic kidney disease: 2021 (SEN-MM).
    Torregrosa JV; Bover J; Rodríguez Portillo M; González Parra E; Dolores Arenas M; Caravaca F; González Casaus ML; Martín-Malo A; Navarro-González JF; Lorenzo V; Molina P; Rodríguez M; Cannata Andia J
    Nefrologia (Engl Ed); 2023 Jun; 43 Suppl 1():1-36. PubMed ID: 37202281
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vitamin D retains an important role in the pathogenesis and management of secondary hyperparathyroidism in chronic renal failure.
    Cozzolino M; Gallieni M; Brancaccio D; Arcidiacono T; Bianchi G; Vezzoli G
    J Nephrol; 2006; 19(5):566-77. PubMed ID: 17136683
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Canadian Society of Nephrology Commentary on the Kidney Disease Improving Global Outcomes 2017 Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder.
    Holden RM; Mustafa RA; Alexander RT; Battistella M; Bevilacqua MU; Knoll G; Mac-Way F; Reslerova M; Wald R; Acott PD; Feltmate P; Grill A; Jindal KK; Karsanji M; Kiberd BA; Mahdavi S; McCarron K; Molnar AO; Pinsk M; Rodd C; Soroka SD; Vinson AJ; Zimmerman D; Clase CM
    Can J Kidney Health Dis; 2020; 7():2054358120944271. PubMed ID: 32821415
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.